EUVIMEDOpdag EUVIMED
Systematische ÜbersichtOpen access · CC BY 4.0

Efficacy and Safety of Transcranial Direct Current Stimulation for Attention Deficit Hyperactivity Disorder: A Meta–Analysis

Liqiong Wang iD, Wenjing Liao iD, Rongwang Yang iD

Alpha Psychiatry · 2025-10-20 · 26 (5)

DOI: 10.31083/ap47294 ↗

At a glance

Systematische Übersicht in Alpha Psychiatry, published online on 2025-10-20. Written by Liqiong Wang and 2 co-authors. Institution: Mental Health Center, Children's Hospital, Zhejiang University School of Medicine, National Clinical Research Center for Child Health, 310052 Hangzho…. Cited 1 times so far (Crossref); 39 references. The full text is freely available (open access, CC BY 4.0). Funded by: National Natural Science Foundation of China.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Background

Attention deficit hyperactivity disorder (ADHD) is one of the most common neurodevelopmental disorders in children. Treatment strategies include psychotherapy, medication, education, and individual support. Recently, transcranial direct current stimulation (tDCS) has emerged as a potential therapeutic option. We undertook this meta–analysis and systematic review to evaluate the efficacy and safety of tDCS for ADHD.

Methods

The PubMed, Embase, Cochrane Library, and Web of Science databases were systematically searched for randomized controlled trials (RCTs) assessing the efficacy of tDCS for ADHD. The search terms included “transcranial direct current stimulation” and “attention deficit hyperactivity disorder”. The search was conducted with no language restrictions, up to the deadline of December 1, 2024. Impulsivity symptoms, inattention, adverse events, and correct responses were analyzed using Stata 15.0.

Results

Seven studies with 290 patients were included. The results of this meta–analysis indicated that tDCS reduced impulsive symptoms [standardized mean difference (SMD) = –0.60, 95% CI (–1.04, –0.16)] as well as inattentive symptoms [SMD = –1.00, 95% CI (–1.95, –0.04)] in patients with ADHD, and did not increase adverse effects [odds ratio (OR) = 1.26, 95% CI (0.67, 2.38)]. Conclusions: tDCS can improve impulsive symptoms and inattentive symptoms in ADHD patients without increasing adverse effects, which is critical in clinical practice, especially when considering non–invasive brain stimulation. The study provided quantitative evidence that tDCS can be used for treating ADHD symptoms without adverse events. The PROSPERO Registration: This study was registered in PROSPERO (CRD42023451277), https://www.crd.york.ac.uk/PROSPERO/view/CRD42023451277.

Subjects

Author keywords

adverse eventattention deficit hyperactivity disordermeta–analysistranscranial direct current stimulation

Authors and institutions

  • Mental Health Center, Children's Hospital, Zhejiang University School of Medicine, National Clinical Research Center for Child Health, 310052 Hangzhou, Zhejiang, China.

ORCID profiles: Liqiong Wang, Wenjing Liao, Rongwang Yang

Funding

  • National Natural Science Foundation of China

Cite

APA

Wang, L., Liao, W., & Yang, R. (2025). Efficacy and Safety of Transcranial Direct Current Stimulation for Attention Deficit Hyperactivity Disorder: A Meta–Analysis. Alpha Psychiatry, 26(5). https://doi.org/10.31083/ap47294

Vancouver

Wang L, Liao W, Yang R. Efficacy and Safety of Transcranial Direct Current Stimulation for Attention Deficit Hyperactivity Disorder: A Meta–Analysis. Alpha Psychiatry. 2025;26(5). doi:10.31083/ap47294

BibTeX
@article{Wang2025,
  author = {Wang, Liqiong and Liao, Wenjing and Yang, Rongwang},
  title = {Efficacy and Safety of Transcranial Direct Current Stimulation for Attention Deficit Hyperactivity Disorder: A Meta–Analysis},
  journal = {Alpha Psychiatry},
  year = {2025},
  volume = {26},
  number = {5},
  doi = {10.31083/ap47294}
}
Start for free →